4-((4-Methoxybenzyl)amino)-4-oxobutanoic acid, 97%, 100mg

(2R,4R)-tert-Butyl 2-(fluoromethyl)-4-hydroxypyrrolidine-1-carboxylate, 95+%, 5g

(2R,3R,4S,5R)-2-(5,6-Dichloro-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 98%, 5mg

5-(4'-(BROMOMETHYL)-[1,1'-BIPHENYL]-2-YL)-2-TRITYL-2H-TETRAZOLE, 95%, 100mg

2-(5-Piperidin-4-yl-1,2,4-oxadiazol-3-yl)pyrazine, 95.0%, 250mg

methyl 2-(2-imino-6-(methylthio)benzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 500mg

2-BROMO-5-CHLORO-4-FLUOROBENZONITRILE, 95.0%, 1g

Methyl 5-methylbenzo[d]oxazole-2-carboxylate, 95.0%, 1g

N-[(1S,2S)-2-Amino-1,2-bis(4-methoxyphenyl)ethyl]-4-methylbenzenesulfonamide, 97%, 100mg

Ultrasonic device Elmasonic P, 18.0 l, P 180H 1 Piece

2-Bromo-5-nitropyrimidine, 95.0%, 250mg

9,10-Bis(phenylethynyl)anthracene, 95.0%, 100g

D(-)-Fructose, min. 99.5%, for biochemistry, 10 kg, plastic packaging.